Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-43,448
Closed -$305K 1020
2025
Q3
$305K Buy
43,448
+235
+0.5% +$1.65K 0.17% 217
2025
Q2
$304K Buy
43,213
+29,019
+204% +$200K 0.44% 79
2025
Q1
$110K Sell
14,194
-3,325
-19% -$28.3K 0.15% 243
2024
Q4
$144K Buy
+17,519
New +$141K 0.12% 349

Other funds holding UDMY

PharVision Advisers's UDMY Position: Q4 2025 in Review

PharVision Advisers sold out of Udemy (UDMY) in Q4 2025, closing a stake of 43,448 shares — an estimated $305K sold.

PharVision Advisers first reported a position in UDMY in Q4 2024 and held it in 4 quarters. The position peaked at $305K in Q3 2025. 183 funds tracked by Wall St. Rank hold UDMY as of Q4 2025.

  • PharVision Advisers reported no remaining Udemy position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 43,448 Udemy shares in Q4 2025, an estimated $305K.
  • PharVision Advisers first reported a position in Udemy in Q4 2024 and held it in 4 quarters.
  • PharVision Advisers's Udemy position peaked at $305K in Q3 2025.
  • 183 funds tracked by Wall St. Rank held Udemy as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.